Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda L Kusner

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Science Immunology|July 7, 2023
Fueling the fire of B cell activationPatricia M Sikorski, Linda L Kusner
Experimental Neurology|June 14, 2015
Editorial: Special issue on standardization of preclinical evaluation of animal models for myasthenia gravisLinda L Kusner, Henry J Kaminski
Annals of the New York Academy of Sciences|December 21, 2012
The role of complement in experimental autoimmune myasthenia gravisLinda L Kusner, Henry J Kaminski
International Review of Neurobiology|July 17, 2025
Animal models of myasthenia gravisPatricia M Sikorski, Linda L Kusner
Med (New York, N.Y.)|April 12, 2026
Autologous CD19/BCMA CAR-T cell therapy for myasthenia gravis: Advancing care for those with severe diseaseHenry J Kaminski, Linda L Kusner
Investigative Ophthalmology & Visual Science|April 28, 2004
Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cellsLinda L Kusner, Vijay P Sarthy, Susanne Mohr
Annals of the New York Academy of Sciences|January 23, 2018
Acetylcholine receptor antibody-mediated animal models of myasthenia gravis and the role of complementLinda L Kusner, Manjistha Sengupta, Henry J Kaminski
Frontiers in Immunology|July 24, 2023
Editorial: Global excellence in inflammatory diseases: North America 2021Linda L Kusner, Ravi S Misra, Rudolf Lucas
Expert Review of Clinical Immunology|May 19, 2010
Effect of complement and its regulation on myasthenia gravis pathogenesisLinda L Kusner, Henry J Kaminski, Jindrich Soltys
The Neurologist|September 23, 2006
Ocular myasthenia: diagnosis, treatment, and pathogenesisLinda L Kusner, Araya Puwanant, Henry J Kaminski
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Science Immunology|July 7, 2023
Fueling the fire of B cell activationPatricia M Sikorski, Linda L Kusner
Experimental Neurology|June 14, 2015
Editorial: Special issue on standardization of preclinical evaluation of animal models for myasthenia gravisLinda L Kusner, Henry J Kaminski
Annals of the New York Academy of Sciences|December 21, 2012
The role of complement in experimental autoimmune myasthenia gravisLinda L Kusner, Henry J Kaminski
International Review of Neurobiology|July 17, 2025
Animal models of myasthenia gravisPatricia M Sikorski, Linda L Kusner
Med (New York, N.Y.)|April 12, 2026
Autologous CD19/BCMA CAR-T cell therapy for myasthenia gravis: Advancing care for those with severe diseaseHenry J Kaminski, Linda L Kusner
Investigative Ophthalmology & Visual Science|April 28, 2004
Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cellsLinda L Kusner, Vijay P Sarthy, Susanne Mohr
Annals of the New York Academy of Sciences|January 23, 2018
Acetylcholine receptor antibody-mediated animal models of myasthenia gravis and the role of complementLinda L Kusner, Manjistha Sengupta, Henry J Kaminski
Frontiers in Immunology|July 24, 2023
Editorial: Global excellence in inflammatory diseases: North America 2021Linda L Kusner, Ravi S Misra, Rudolf Lucas
Expert Review of Clinical Immunology|May 19, 2010
Effect of complement and its regulation on myasthenia gravis pathogenesisLinda L Kusner, Henry J Kaminski, Jindrich Soltys
The Neurologist|September 23, 2006
Ocular myasthenia: diagnosis, treatment, and pathogenesisLinda L Kusner, Araya Puwanant, Henry J Kaminski
Pageof 5